MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection: a Diagnostic Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 280
- 试验地点
- 1
- 主要终点
- The different of MiR-223 level between gastric cancer and control group
研究概览
简要总结
The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients.
The main question it aims to answer is:
- Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer?
Participants will be asked for their consent to obtain 5 cc of blood.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- •Patients who cannot give informed consent
- •Pregnancy
结局指标
主要结局
The different of MiR-223 level between gastric cancer and control group
时间窗: Day 1
The different of MiR-223 level between gastric cancer and control group
The different of MiR-106b level between gastric cancer and control group
时间窗: Day 1
The different of MiR-106b level between gastric cancer and control group
The different of MiR-199a level between gastric cancer and control group
时间窗: Day 1
The different of MiR-199a level between gastric cancer and control group
The different of MiR-20a level between gastric cancer and control group
时间窗: Day 1
The different of MiR-20a level between gastric cancer and control group
The different of MiR-21 level between gastric cancer and control group
时间窗: Day 1
The different of MiR-21 level between gastric cancer and control group
次要结局
未报告次要终点
研究者
Rapat Pittayanon
Associate Professor
King Chulalongkorn Memorial Hospital